Header Leaderboard Ad

Collapse

BGI Shenzhen Acquires Complete Genomics

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • BGI Shenzhen Acquires Complete Genomics

    MOUNTAIN VIEW, Calif. (AP) -- Chinese genomics company BGI-Shenzhen is buying Complete Genomics for approximately $113.1 million, the companies said Monday. ( http://finance.yahoo.com/news/bgi-sh...150425317.html )

    gnews: http://www.google.com/search?hl=en&g....1.q-26R06iZ5I

    Blog coverage:

    omix: http://omicsomics.blogspot.co.uk/201...-genomics.html

    dscan: http://www.genomeweb.com/blog/bgi-stakes-claim

    hlogus: http://www.homolog.us/blogs/2012/09/...-21st-century/

  • #2
    Now BGI gets their US front... And CG is sparred a slow and painful demise...

    Comment


    • #3
      Originally posted by adaptivegenome View Post
      Now BGI gets their US front... And CG is sparred a slow and painful demise...
      And I get $3 a share. Whoo!

      Comment


      • #4
        Originally posted by pbluescript View Post
        And I get $3 a share. Whoo!
        Maybe they'll pay you in RMB's (also know as Yuan's).

        Comment


        • #5
          Originally posted by adaptivegenome View Post
          And CG is spared a slow and painful demise...
          Are you sure about that?

          Comment


          • #6
            Originally posted by Geneus View Post
            Maybe they'll pay you in RMB's (also know as Yuan's).
            It does sound a bit better at 18RMB/share.

            Comment


            • #7
              Despite the annoyingly short reads (and my low expectations), the CGI whole genomes aren't that bad. At the reported $5K a pop, it seems pretty cheap.

              Questions I'd have are:

              Wasn't BGI a research institute? Now it's all o' the sudden an M&A "player" ???

              If they're now a now a commercial venture, then what's their path to profit? Are they going to sell their "we sequenced everything" knowledge? Are they going to use cheap labor and "economies of scale" to make the commercial clinical market happen? Will the sample from your next Labcorp visit get fedexed to Hong Kong and processed over there?

              Is there "intellectual property" in CGI? Is this just loading up ammo for potential Samsung/Apple type legal battles? Is there some tech that CGI has that needs more capital to exploit?

              Is there value in CGI salesforce? Perhaps this gives BGI some recon troops on the ground in the world's biggest market.

              Is there some "synergistic" opportunity going down here?

              Comment


              • #8
                Originally posted by Richard Finney View Post
                Despite the annoyingly short reads (and my low expectations), the CGI whole genomes aren't that bad. At the reported $5K a pop, it seems pretty cheap.

                Questions I'd have are:

                Wasn't BGI a research institute? Now it's all o' the sudden an M&A "player" ???

                If they're now a now a commercial venture, then what's their path to profit? Are they going to sell their "we sequenced everything" knowledge? Are they going to use cheap labor and "economies of scale" to make the commercial clinical market happen? Will the sample from your next Labcorp visit get fedexed to Hong Kong and processed over there?

                Is there "intellectual property" in CGI? Is this just loading up ammo for potential Samsung/Apple type legal battles? Is there some tech that CGI has that needs more capital to exploit?

                Is there value in CGI salesforce? Perhaps this gives BGI some recon troops on the ground in the world's biggest market.

                Is there some "synergistic" opportunity going down here?
                Lots of questions...for answers, "only the Shadow knows."

                Comment


                • #9
                  BGI is not a research institute. It is a company that does some research...

                  Comment


                  • #10
                    Originally posted by Richard Finney View Post
                    Wasn't BGI a research institute? Now it's all o' the sudden an M&A "player" ???

                    Is there "intellectual property" in CGI? Is this just loading up ammo for potential Samsung/Apple type legal battles? Is there some tech that CGI has that needs more capital to exploit?
                    BGI I think is a bit of a hybrid beast, with some aspects non-profit and some more on a for-profit bent. This has precedent in the U.S. (TIGR as non-profit & HGS as for-profit -- original setup but it did not last), but who knows what structure is available in China.

                    CG would be expected to have IP around their sequencing process. A BioIT article states they have two issued patents around their Long Fragment Read technology for library preparation.
                    Google found an interesting little list of patents for CG, though I cannot vouch it is complete nor accurate.

                    Comment


                    • #11
                      Originally posted by krobison View Post
                      BGI I think is a bit of a hybrid beast, with some aspects non-profit and some more on a for-profit bent. This has precedent in the U.S. (TIGR as non-profit & HGS as for-profit -- original setup but it did not last), but who knows what structure is available in China.

                      CG would be expected to have IP around their sequencing process. A BioIT article states they have two issued patents around their Long Fragment Read technology for library preparation.
                      Google found an interesting little list of patents for CG, though I cannot vouch it is complete nor accurate.
                      Don't be naive...BGI wants to dominate the world of sequencing...plain and simple. They obviously shy away from that question if it is breached... but trust me, I know this to be the fact.

                      Comment


                      • #12
                        Welp.
                        Kinda leads to an obvious question:
                        Who owns BGI Shenzhen ?
                        Last edited by Richard Finney; 09-21-2012, 06:57 AM. Reason: pinyin spelling

                        Comment


                        • #13
                          My guess is that they wanted their own sequencing technology and this was the only one for sale. Having a customer list is a plus. Looks like there will now be three sequencing technologies on the market?

                          Comment


                          • #14
                            Bloomberg story from 9/17/2012:
                            http://www.bloomberg.com/news/2012-0...tml?cmpid=yhoo

                            More Accurate

                            Complete Genomics’s sequencing technology gives results slower than that of Illumina Inc. (ILMN), BGI’s major supplier of sequencing machines, said George Church, who advises both Complete Genomics and BGI. However, studies have shown that the technology BGI is acquiring is more accurate than Illumina’s, and Complete Genomics has the potential give results in a time frame that will be useful to doctors, Church said.

                            The purchase may also reduce BGI’s dependence on Illumina and sequencer-maker Life Technology Corp., said Doug Schenkel, an analyst with Cowen and Co. in Boston.

                            Most medical genetic testing in the U.S. is overseen by the Centers for Medicare & Medicaid Services under the Clinical Laboratory Improvements Amendment. Complete Genomics has said it expects CLIA approval for a lab this year. The lab would compete with San Diego-based Illumina Inc., which provides clinical genome-analysis services.

                            IBD story:
                            http://finance.yahoo.com/news/china-...120200945.html

                            BGI wants to enter the U.S. market for research and medical DNA testing.

                            Comment


                            • #15
                              Originally posted by Richard Finney View Post

                              BGI wants to enter the U.S. market for research and medical DNA testing.

                              Were you aware that BGI sent several (at least 5...perhaps 10?) HiSeqs earlier this year to the CHOP? That lab is already CLIA.

                              Comment

                              Latest Articles

                              Collapse

                              • seqadmin
                                A Brief Overview and Common Challenges in Single-cell Sequencing Analysis
                                by seqadmin


                                ​​​​​​The introduction of single-cell sequencing has advanced the ability to study cell-to-cell heterogeneity. Its use has improved our understanding of somatic mutations1, cell lineages2, cellular diversity and regulation3, and development in multicellular organisms4. Single-cell sequencing encompasses hundreds of techniques with different approaches to studying the genomes, transcriptomes, epigenomes, and other omics of individual cells. The analysis of single-cell sequencing data i...

                                01-24-2023, 01:19 PM
                              • seqadmin
                                Introduction to Single-Cell Sequencing
                                by seqadmin
                                Single-cell sequencing is a technique used to investigate the genome, transcriptome, epigenome, and other omics of individual cells using high-throughput sequencing. This technology has provided many scientific breakthroughs and continues to be applied across many fields, including microbiology, oncology, immunology, neurobiology, precision medicine, and stem cell research.

                                The advancement of single-cell sequencing began in 2009 when Tang et al. investigated the single-cell transcriptomes
                                ...
                                01-09-2023, 03:10 PM

                              ad_right_rmr

                              Collapse
                              Working...
                              X